Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 55.93

-0.6%

Dec 16 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Steve168 who wrote (14915)	12/24/2004 10:21:36 AM
From: fred hayes	Read Replies (1) of 52153

Praecis: looks undervalued on its face, but I gave up on it. If you think their drug for prostate cancer (abarelix sp?)will sell, then PRCS is a bargain. So far, the docs don't seem to want it. It is a hassle to deal with, sales have been in the toilet, and its difficult to keep tabs on progress. I sold my position and don't follow it anymore. I don't think others on this board follow it either, it has not been discussed for a long time... fred hayes

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next